China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firms Allplex 2019-nCoV Assay, a real-time RT-PCR te

Exact Sciences reported on Tuesday after the close of the market that its preliminary first quarter revenues are expected to rise about 115 percent, despite the negative impact of the COVID-19 pandemic on orders for its Cologuard colorectal

Austrian biopharma firm Viravaxx said on Tuesday that it is collaborating with the Medical University of Vienna to create a platform for diagnostic and vaccine research into COVID-19. The collaborators will use a protein microarray comprisi

A group of life sciences and bioinformatics companies have banded together in the race to find treatments, vaccines, and a cure for COVID-19. The fledgling EndPandemic National Data Consortium said last week that seven firms have signed on

Envisagenics announced Tuesday it has entered into a research program agreement with Johnson Johnsons Lung Cancer Initiative (LCI.) Under the terms of the agreement, Envisagenics will build predictive models for lung cancer progression and

Applied DNA Sciences said on Tuesday that it has partnered with Stony Brook University Hospital to validate the companys SARS-CoV-2 diagnostic. Called LineaCOVID-19, the test is designed to detect and quantify SARS-CoV-2 nucleic acid. Under

The increasing number of original reference biologics coming off patent over the past few years is well known within the pharmaceutical industry with 17 coming off patent in Europe between 20182023 (1). The result is a substantial increase

Although both share a preference for use of oral solid-dosage forms, the business model for consumer pharmaceutical manufacturersoften called over-the-counter (OTC) manufacturers in the United Statesdiffers significantly from that of prescr

SPI Pharma has expanded its Mannogem mannitol product line for use in oral solid dosage (OSD) forms, offering a new Precious Gem Collection. Its goal is to address challenges that the crystalline sugar alcohol excipient poses for formulator

4D pharma, a pharmaceutical company headquartered in the United Kingdom, announced on April 20, 2020 that it has received expedited acceptance from the UK Medicines and Healthcare products Regulatory Agency to launch a phase-II study of MRx